Tilray Brands' Reverse Stock Split: A Strategic Move Amidst Market Fluctuations

Core Insights - Tilray Brands, listed on NASDAQ as TLRY, is a significant player in the cannabis industry, focusing on the production and distribution of medical and recreational cannabis products [1][4] - The company executed a reverse stock split at a ratio of 10 for 1 on December 2, 2025, to consolidate shares and potentially stabilize its stock price [1][4] - Despite the reverse stock split, Tilray's shares have faced a substantial decline, with a nearly 40% loss in 2025 and a recent drop of over 20% in a trading session [2][4] Stock Performance - Following the reverse stock split, the total number of outstanding shares was reduced from approximately 1.16 billion to 116 million [2][4] - Currently, Tilray's stock is priced at $8.64, reflecting a 10.49% increase with a change of $0.82, and a trading volume of 5.37 million shares indicates active investor interest [3] - The stock has experienced significant fluctuations, with a low of $7.17 and a high of $8.95 in a single day, suggesting potential for further selling pressure [3]